Literature DB >> 2405872

Intrasplenic immunization with minute amounts of antigen.

B O Nilsson1, A Larsson.   

Abstract

There are two ways to raise antibodies to minute amounts of immunogen. The first is in-vitro immunization in which the immunogen is presented to a spleen cell culture and about a week later cell fusion for hybridoma production is attempted. The second, and the subject of this review, is intrasplenic immunization, in which the immunogen is deposited into the spleen tissue and the animal itself takes care of growing the spleen cells. Both of these techniques are appropriate when only small amounts of immunogen are available. Intrasplenic immunization, however, requires less laboratory work and there is a decreased risk of contamination, often a problem with hybridoma cultures. The experience of intrasplenic immunization shows that it is the method of choice for immunization with nanogram amounts of immunogen. A successful outcome, however, requires that the immunogen is immobilized on a carrier. This review by Ove Nilsson and Anders Larsson will focus on the various types of matrix which can be used as carriers and on the procedures for transferring these carriers into the spleen tissue.

Mesh:

Substances:

Year:  1990        PMID: 2405872     DOI: 10.1016/0167-5699(90)90004-s

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  3 in total

1.  Sequence of a new Bowman-Birk inhibitor from Torresea acreana seeds and comparison with Torresea cearensis trypsin inhibitor (TcTI2).

Authors:  A S Tanaka; M U Sampaio; R Mentele; E A Auerswald; C A Sampaio
Journal:  J Protein Chem       Date:  1996-08

2.  Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma.

Authors:  Y Zhang; Y Deng; T Wendt; B Liliensiek; A Bierhaus; J Greten; W He; B Chen; V Hach-Wunderle; R Waldherr; R Ziegler; D Männel; D M Stern; P P Nawroth
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

3.  Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes.

Authors:  J L Johnson; T G Beito; C J Krco; D O Toft
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.